Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neuroblastoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Ganglioneuroblastoma 3Burkitt Lymphoma 3Urinary Bladder Neoplasms 2Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Biphenotypic, Acute 2Breast Neoplasms 2Teratoma 1Squamous Cell Carcinoma of Head and Neck 1Rhabdomyosarcoma, Alveolar 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lung Neoplasms 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia 1

Interventions

trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1taxane 1pertuzumab 1Trastuzumab 1Taxoids 1Steroids 1Specimen Handling 1Radiotherapy 1Radiosurgery 1Radiation 1PF-05280014 1Ontruzant 1Ogivri 1Mastectomy, Simple 1Mastectomy, Segmental 1Magnetic Resonance Spectroscopy 1Hormones 1High-Energy Shock Waves 1Cyclin-Dependent Kinase Inhibitor p18 1Cyclin-Dependent Kinase Inhibitor p16 1CT-P6 1Biopsy 1Ado-Trastuzumab Emtansine 12C4 antibody 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Anatomic Stage IV Breast Cancer AJCC v8 × Biopsy × Clear all
NCT07578116 2026-05-27

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

SWOG Cancer Research Network

Phase 3 Not yet recruiting
562 enrolled
Breast

Anatomic Stage IV Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡